These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9284727)

  • 21. The effect of octreotide and bromocriptine on expression of a pro-apoptotic Bax protein in rat prolactinoma.
    Gruszka A; Kunert-Radek J; Pawlikowski M
    Folia Histochem Cytobiol; 2004; 42(1):35-9. PubMed ID: 15046398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid re-enlargement of a macroprolactinoma after initial shrinkage in a young woman treated with bromocriptine.
    Adler I; Barsi P; Czirják S; Varga I; Gergics P; Jakab C; Rácz K
    Gynecol Endocrinol; 2005 Jun; 20(6):317-21. PubMed ID: 16019380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolution of a prolactin-secreting pituitary microadenoma into a fatal carcinoma: a case report.
    Guastamacchia E; Triggiani V; Tafaro E; De Tommasi A; De Tommasi C; Luzzi S; Sabbà C; Resta F; Terreni MR; Losa M
    Minerva Endocrinol; 2007 Sep; 32(3):231-6. PubMed ID: 17912159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-tumoral action of octreotide and bromocriptine on the experimental rat prolactinoma: anti-proliferative and pro-apoptotic effects.
    Gruszka A; Pawlikowski M; Kunert-Radek J
    Neuro Endocrinol Lett; 2001 Oct; 22(5):343-8. PubMed ID: 11600876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of prolactinomas and growth hormone-producing adenomas with an injectable bromocriptine retard preparation and a somatostatin analogue delivered by an implantable pump.
    Schatz H; Stracke H; Hildebrandt G
    Pathol Res Pract; 1988 Sep; 183(5):546-51. PubMed ID: 3237541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pituitary apoplexy within a macroprolactinoma.
    Watt A; Pobereskin L; Vaidya B
    Nat Clin Pract Endocrinol Metab; 2008 Nov; 4(11):635-41. PubMed ID: 18797434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia.
    Colao A; Di Sarno A; Cappabianca P; Di Somma C; Pivonello R; Lombardi G
    N Engl J Med; 2003 Nov; 349(21):2023-33. PubMed ID: 14627787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size.
    Bevan JS; Atkin SL; Atkinson AB; Bouloux PM; Hanna F; Harris PE; James RA; McConnell M; Roberts GA; Scanlon MF; Stewart PM; Teasdale E; Turner HE; Wass JA; Wardlaw JM
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4554-63. PubMed ID: 12364434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical practice. Prolactinomas.
    Klibanski A
    N Engl J Med; 2010 Apr; 362(13):1219-26. PubMed ID: 20357284
    [No Abstract]   [Full Text] [Related]  

  • 30. Cabergoline treatment in a case of macroprolactinoma after delivery.
    Falsetti L
    Acta Eur Fertil; 1995; 26(3):105-7. PubMed ID: 9098469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting therapeutic response and degree of pituitary tumour shrinkage during treatment of acromegaly with octreotide LAR.
    Jenkins PJ; Emery M; Howling SJ; Evanson J; Besser GM; Monson JP
    Horm Res; 2004; 62(5):227-32. PubMed ID: 15477693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impressive shrinkage of a giant prolactinoma treated with cabergoline in a prepubescent girl. What now?
    Christoforidis A; Tsakalides C; Anastasiou A; Pavlaki A; Dimitriadou M
    Neuro Endocrinol Lett; 2013; 34(4):275-7. PubMed ID: 23803868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cabergoline-induced CSF rhinorrhea in patients with macroprolactinoma. Report of three cases.
    Cappabianca P; Lodrini S; Felisati G; Peca C; Cozzi R; Di Sarno A; Cavallo LM; Giombini S; Colao A
    J Endocrinol Invest; 2001 Mar; 24(3):183-7. PubMed ID: 11314748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas.
    Ono M; Miki N; Amano K; Kawamata T; Seki T; Makino R; Takano K; Izumi S; Okada Y; Hori T
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2672-9. PubMed ID: 20357175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Medical treatment of prolactin and growth hormone-secreting pituitary tumors].
    Jadresic A
    Rev Med Chil; 1997 Nov; 125(11):1383-8. PubMed ID: 9609063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis of prolactinoma in two male-to-female transsexual subjects following high-dose cross-sex hormone therapy.
    Cunha FS; Domenice S; Câmara VL; Sircili MH; Gooren LJ; Mendonça BB; Costa EM
    Andrologia; 2015 Aug; 47(6):680-4. PubMed ID: 25059808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proptosis as the presenting sign of giant prolactinoma in a prepubertal boy: successful resolution of hydrocephalus by use of medical therapy.
    Cackett P; Eunson G; Bath L; Mulvihill A
    Future Oncol; 2012 Dec; 8(12):1621-6. PubMed ID: 23231524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant prolactinoma with extracranial metastases: a report of three cases.
    Walker JD; Grossman A; Anderson JV; Ur E; Trainer PJ; Benn J; Lowy C; Sönksen PH; Plowman PN; Lowe DG
    Clin Endocrinol (Oxf); 1993 Apr; 38(4):411-9. PubMed ID: 8319373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dramatic shrinkage of a giant prolactinoma in a male patient under medical management.
    Ippersiel W; Misson N; Donckier JE
    Acta Clin Belg; 2012; 67(2):140-1. PubMed ID: 22712173
    [No Abstract]   [Full Text] [Related]  

  • 40. Pituitary Apoplexy in Long-Term Cabergoline User During Thrombocytopenia Due to Chemotherapy for Chronic Myelocytic Leukemia.
    Maki Y; Kurosaki Y; Uchino K; Ishibashi R; Chin M; Yamagata S
    World Neurosurg; 2018 Dec; 120():290-295. PubMed ID: 30189305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.